Q3 2019

Filed Nov 15, 2019 · 10-Q · 46 days after period end · 0001493152-19-017792

Q3 2019 · 10-Q

Revenue

$0.00

derivedno prior Q3 2018 on file

Net Income

-$31.88K

no prior Q3 2018 on file

EPS Diluted

$0.00

no prior Q3 2018 on file

Operating Income-$31,894—

Same quarter

no prior Q3 2018 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2019 · filed Nov 15, 2019 · 46 d after period end

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR